![Emily Crossley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emily Crossley is the founder of Duchenne UK, which is founded in 2012, where she currently holds the title of Joint Chief Executive Officer.
She is also currently a Director at Duchenne Research (UK) Investment Ltd.
| Companies | Position | Start |
|---|---|---|
Duchenne UK
 Duchenne UK Investment Trusts/Mutual FundsMiscellaneous Operates as charitable trust to fund and accelerate treatments and cure for muscular dystrophy | Chief Executive Officer | 31/12/2011 |
Duchenne Research (UK) Investment Ltd.
 Duchenne Research (UK) Investment Ltd. BiotechnologyHealth Technology Provides biotechnology research and experimental development services | Director/Board Member | 04/01/2016 |
Active
Inactive
Listed companies
Private companies
| Private companies | 2 |
|---|---|
Duchenne UK
Duchenne UK Investment Trusts/Mutual FundsMiscellaneous Operates as charitable trust to fund and accelerate treatments and cure for muscular dystrophy | Miscellaneous |
Duchenne Research (UK) Investment Ltd.
Duchenne Research (UK) Investment Ltd. BiotechnologyHealth Technology Provides biotechnology research and experimental development services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
